NCT01622764 2024-05-06
89Zr-RO5323441 PET Imaging in Glioblastoma
University Medical Center Groningen
Phase 2 Withdrawn
Clinical Trials
3 trialsNCT02748135 2021-01-13
A Study of TB-403 in Pediatric Subjects With Relapsed or Refractory Medulloblastoma
Oncurious NV
Phase 1 Completed
NCT01308684 2016-11-02
A Dose- and Efficacy-Finding Study of RO5323441 in Combination With Avastin (Bevacizumab) in Patients With Recurrent Glioblastoma
Hoffmann-La Roche
Phase 1 Completed